Skip to content
Home/Companies/Pharma/Advanthera
Advanthera

Advanthera

Pharma·Spain·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Advanthera?

Advanthera is currently owned by Columbus Venture Partners through Columbus Life Sciences Fund IV (2023 vintage), since 2024.

Hand-verified · updated 2026-08-09

Columbus Venture Partners
Investor
Columbus Venture Partners
Columbus Life Sciences Fund IV · 2023 · Life Sciences VC

Key facts

HQSpain
SectorPharma
StatusActive
Websiteadvanthera.com

More from Columbus Life Sciences Fund IV

Other portfolio companies in the same fund.

Accipiter Biosciences
Accipiter Biosciences
Active
BiotechUS· 2025
DeepUll
Active
HealthTechSpain· 2025
Quibim
Active
HealthTechSpain· 2025
Aleta Biotherapeutics
Aleta Biotherapeutics
Active
BiotechUS· 2024
Cocoon Bioscience
Cocoon Bioscience
Active
BiotechSpain· 2024
Curve Therapeutics
Curve Therapeutics
Active
BiotechUK· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Advanthera

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Advanthera?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Advanthera.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue